ResearcherFriedrich-Alexander-Universität Erlangen-NürnbergActive in the last 2 years
Marc P. Stemmler
Matched on ORCID iD 0000-0002-7866-3686; OpenAlex author ID A5032655156. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 41
2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 7
- DNA methylation-based classification uncovers acinar and ductal origins for KPC-derived PDAC cell lines. Co-author DOI 10.1016/j.canlet.2026.218666↗
- Pancreatic cancer relies on opposing signalling pathways to drive its cellular diversity. Co-author DOI 10.1038/d41586-025-03133-1↗
- Roflumilast inhibits tumor growth and migration in STK11/LKB1 deficient pancreatic cancer. Co-author DOI 10.1038/s41420-024-01890-y↗
- Editorial: Translational Insights Into Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/fcell.2022.875836↗
- Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer. Co-author DOI 10.3389/fcell.2021.753456↗
- ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancrea… Co-author DOI 10.1053/j.gastro.2019.10.038↗
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Co-author DOI 10.1038/ncb3513↗
Closest collaborators
The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Thomas Brabletz · 3 shared papers, 2017–2021 · strength 0.34
- Paper Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer. DOI 10.3389/fcell.2021.753456↗
- Paper ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the… DOI 10.1053/j.gastro.2019.10.038↗
- Paper The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. DOI 10.1038/ncb3513↗
- Peter J. Bailey · 1 shared paper, 2022 · strength 0.26
- Maarten F. Bijlsma · 1 shared paper, 2022 · strength 0.26
- Mario A. Shields · 1 shared paper, 2026 · strength 0.24
- Rémy Nicolle · 1 shared paper, 2026 · strength 0.24
- Sofia Ferreira · 1 shared paper, 2026 · strength 0.24
- Ilianna Zoi · 1 shared paper, 2026 · strength 0.24
- Malak Haidar · 1 shared paper, 2026 · strength 0.24
- Ben Z. Stanger · 1 shared paper, 2026 · strength 0.24
- Janel L. Kopp · 1 shared paper, 2026 · strength 0.24
- Laura D Attardi · 1 shared paper, 2026 · strength 0.24
- Patrick Jacquemin · 1 shared paper, 2026 · strength 0.24
- Christian P. Pilarsky · 2 shared papers, 2017–2024 · strength 0.20
- Ruthger van Roey · 1 shared paper, 2021 · strength 0.19
- Isabell Armstark · 1 shared paper, 2021 · strength 0.19
- Yanxi Lu · 1 shared paper, 2024 · strength 0.15
- Jinping Zhang · 1 shared paper, 2024 · strength 0.15
- Hai Yang · 1 shared paper, 2024 · strength 0.15
- Duo Yun · 1 shared paper, 2024 · strength 0.15
- Bin Lan · 1 shared paper, 2024 · strength 0.15
- Nathalie Britzen‐Laurent · 1 shared paper, 2024 · strength 0.15
- Eva Lentsch · 1 shared paper, 2024 · strength 0.15
- Hang He · 1 shared paper, 2024 · strength 0.15
- Shuman Zhang · 1 shared paper, 2024 · strength 0.15
- Hao Yang · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.